301230.SZ · 泓博医药
China A-shares · RS rating 68 · As of 2026-10-14
| Price | 32.91 CNY |
|---|---|
| 1-day change | -3.9% |
| RS rating (overall / 1M / 3M / 12M) | 68 / 93 / 37 / 60 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 35 / 35 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +11.5% |
| Distance from 52-week high | +50.0% |
| Market cap (USD) | $985.5M |